A three-pronged acne treatment known as IDP-26 demonstrated greater efficacy than single and double treatments recently in matching randomized phase 3 trials.
IDP-126 gel is a fixed-dose therapy consisting of topical clindamycin phosphate 1.2%, adapalene 0.15%, and benzoyl peroxide 3.1%. The report was published in JAAD.
The 12-week studies randomized participants ages 9 or older with moderate or severe acne (n=183 and n=180, respectively) to receive either daily IDP-126 or a control treatment.
|